SF3B1 mutations are recurrent in chronic lymphocytic leukemia (CLL), particularly enriched in clinically aggressive stereotyped subset #2. To investigate their impact, we conducted RNA-sequencing of 18 SF3B1MUT and 17 SF3B1WT subset #2 cases and identified 80 significant alternative splicing events (ASEs). Notable ASEs concerned exon inclusion in the non-canonical BAF (ncBAF) chromatin remodeling complex subunit, BRD9, and splice variants in eight additional ncBAF complex interactors. Long-read RNA-sequencing confirmed the presence of splice variants, and extended analysis of 139 CLL cases corroborated their association with SF3B1 mutations. Overexpression of SF3B1K700E induced exon inclusion in BRD9, resulting in a novel splice isoform with an alternative C-terminus. Protein interactome analysis of the BRD9 splice isoform revealed augmented ncBAF complex interaction, while exhibiting decreased binding of auxiliary proteins, including SPEN, BRCA2, and CHD9. Additionally, integrative multi-omics analysis identified a ncBAF complex-bound gene quartet on chromosome 1 with higher expression levels and more accessible chromatin in SF3B1MUT CLL. Finally, Cancer Dependency Map analysis and BRD9 inhibition displayed BRD9 dependency and sensitivity in cell lines and primary CLL cells. In conclusion, spliceosome dysregulation caused by SF3B1 mutations leads to multiple ASEs and an altered ncBAF complex interactome, highlighting a novel pathobiological mechanism in SF3B1MUT CLL.
- MeSH
- alternativní sestřih MeSH
- chronická lymfatická leukemie * genetika patologie metabolismus MeSH
- fosfoproteiny * genetika metabolismus MeSH
- lidé MeSH
- mutace * MeSH
- proteiny obsahující bromodoménu MeSH
- restrukturace chromatinu * MeSH
- sestřihové faktory * genetika metabolismus MeSH
- spliceozomy * metabolismus genetika MeSH
- transkripční faktory genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- BRD9 protein, human MeSH Prohlížeč
- fosfoproteiny * MeSH
- proteiny obsahující bromodoménu MeSH
- sestřihové faktory * MeSH
- SF3B1 protein, human MeSH Prohlížeč
- transkripční faktory MeSH
The NFKBIE gene, which encodes the NF-κB inhibitor IκBε, is mutated in 3-7% of patients with chronic lymphocytic leukemia (CLL). The most recurrent alteration is a 4-bp frameshift deletion associated with NF-κB activation in leukemic B cells and poor clinical outcome. To study the functional consequences of NFKBIE gene inactivation, both in vitro and in vivo, we engineered CLL B cells and CLL-prone mice to stably down-regulate NFKBIE expression and investigated its role in controlling NF-κB activity and disease expansion. We found that IκBε loss leads to NF-κB pathway activation and promotes both migration and proliferation of CLL cells in a dose-dependent manner. Importantly, NFKBIE inactivation was sufficient to induce a more rapid expansion of the CLL clone in lymphoid organs and contributed to the development of an aggressive disease with a shortened survival in both xenografts and genetically modified mice. IκBε deficiency was associated with an alteration of the MAPK pathway, also confirmed by RNA-sequencing in NFKBIE-mutated patient samples, and resistance to the BTK inhibitor ibrutinib. In summary, our work underscores the multimodal relevance of the NF-κB pathway in CLL and paves the way to translate these findings into novel therapeutic options.
- MeSH
- adenin analogy a deriváty farmakologie MeSH
- chronická lymfatická leukemie * genetika patologie metabolismus farmakoterapie MeSH
- lidé MeSH
- myši MeSH
- NF-kappa B * metabolismus MeSH
- piperidiny farmakologie MeSH
- pohyb buněk MeSH
- proliferace buněk MeSH
- proteiny I-kappa B * genetika metabolismus MeSH
- protoonkogenní proteiny genetika metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- adenin MeSH
- ibrutinib MeSH Prohlížeč
- NF-kappa B * MeSH
- NFKBIE protein, human MeSH Prohlížeč
- piperidiny MeSH
- proteiny I-kappa B * MeSH
- protoonkogenní proteiny MeSH